当前位置:首页 - 行情中心 - 真视通(002771) - 财务分析 - 利润表

真视通

(002771)

  

流通市值:33.45亿  总市值:40.21亿
流通股本:1.75亿   总股本:2.10亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入243,016,110.06169,857,243.3281,365,116.88446,958,432.82
营业收入243,016,110.06169,857,243.3281,365,116.88446,958,432.82
二、营业总成本304,606,287.93208,674,250.9997,568,303.58495,805,924.51
营业成本210,783,536.93145,453,849.9569,131,524.12350,121,144.84
税金及附加1,381,605.51,001,839.61271,132.52,879,199.78
销售费用19,961,603.7113,751,143.725,875,766.5429,780,443.78
管理费用46,051,476.3430,799,676.7114,757,292.3870,549,371.93
研发费用26,676,42016,748,824.417,076,959.2841,496,042.74
财务费用-248,354.55918,916.59455,628.76979,721.44
其中:利息费用2,809,7961,815,148.69819,981.222,579,404.78
其中:利息收入3,266,863.421,026,864.24378,885.931,884,542.51
加:公允价值变动收益-172,236.72-753,535.65--1,054,949.91
加:投资收益-1,283,300.99-899,690.17-360,366.618,569,498.29
资产处置收益1,911.041,911.04--
资产减值损失(新)1,476,982.251,362,446.44840,532.62-11,362,680.6
信用减值损失(新)35,132,779.1823,484,657.5322,369,261.67-19,704,470.52
其他收益1,959,234.31638,897.2555,650.531,519,140.42
营业利润平衡项目0000
四、营业利润-24,474,808.8-14,982,321.287,201,891.52-60,880,954.01
加:营业外收入651,239.1630,008.24630,006.62198,972.4
减:营业外支出815,687.59769,633.16324,712.1713,732.63
利润总额平衡项目0000
五、利润总额-24,639,257.29-15,121,946.27,507,186.04-61,395,714.24
减:所得税费用4,612,623.723,091,886.942,915,686.46-3,244,236.06
六、净利润-29,251,881.01-18,213,833.144,591,499.58-58,151,478.18
持续经营净利润-29,251,881.01-18,213,833.144,591,499.58-58,151,478.18
归属于母公司股东的净利润-23,062,619.7-13,884,026.016,734,522-48,868,351.3
少数股东损益-6,189,261.31-4,329,807.13-2,143,022.42-9,283,126.88
(一)基本每股收益-0.11-0.070.03-0.23
(二)稀释每股收益-0.11-0.070.03-0.23
八、其他综合收益1,027,189.731,085,094.81-41,298.49-2,340,191.33
归属于母公司股东的其他综合收益1,027,189.731,085,094.81-41,298.49-2,340,191.33
九、综合收益总额-28,224,691.28-17,128,738.334,550,201.09-60,491,669.51
归属于母公司股东的综合收益总额-22,035,429.97-12,798,931.26,693,223.51-51,208,542.63
归属于少数股东的综合收益总额-6,189,261.31-4,329,807.13-2,143,022.42-9,283,126.88
公告日期2024-10-232024-08-292024-04-262024-04-26
审计意见(境内)标准无保留意见
TOP↑